B CELL REGULATION BY INTERLEUKIN 5 PLUS ANTIGEN
B CELL REGULATION BY INTERLEUKIN 5 PLUS ANTIGEN
批准号:
2183943
负责人:
Carol F Webb
金额:
$11.02万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-08-01 至 1997-07-31
关键词:
B lymphocyte DNA binding protein DNA topoisomerases T lymphocyte chemical binding gel mobility shift assay gene expression hemocyanin immunoglobulin genes interleukin 5 laboratory mouse leukocyte activation /transformation molecular cloning nuclear matrix phosphorylation protein biosynthesis protein purification protein structure function transfection ultraviolet radiation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The mechanisms by which antibody genes are regulated in a cell type-
specific manner in response to cytokines and antigenic stimuli is poorly
understood. We have developed a model system to study the mechanisms by
which the antigen, phosphocholine, and the cytokine, interleukin-5,
influence B cell differentiation and have found that IL-5 + antigen
caused increased transcription of mu immunoglobulin genes. Several DNA-
binding proteins that may be important in mitogen-stimulated or basal
immunoglobulin transcription have been shown to bind within 200 base
pairs of the transcription start site. IL-5+ antigen induced increases
in B cell-specific mobility-shifted protein-DNA complexes that bound to
A+T rich sequences 200 to 500 base pairs 5' of the transcription start
site. These protein-DNA complexes probably contain more than one
protein. In the proposed studies, these proteins will be characterized
and their functions will be investigated.
The broad objective of this research is to identify some of the
regulatory events that occur in B cells in response to IL-5+ antigen.
The specific goals are: (1) to determine the molecular basis for the B
cell-specific mobility of the previously identified IL-5+ antigen
inducible DNA-protein complexes, (2) to determine whether the proteins
in this complex regulate transcription by functioning as topoisomerases,
DNA-bending proteins, or components of the nuclear matrix, and (3) to
test whether these proteins are involved in maintaining B cell-specific
immunoglobulin transcription. Proteins will be further characterized
using UV crosslinking and mobility shift assays. Total understanding of
the role these proteins play in transcription may require in vitro
systems. Therefore, individual proteins will be enriched by conventional
methods and purified with affinity columns. Genes encoding proteins that
appear to be important in the response to IL-5+ antigen will be cloned
using conventional and/or expression libraries.
Preliminary data indicates that protein complexes from T cell extracts
also bind to these sequences, and that these complexes contain some
proteins different than those found in the B cell complexes. Other
proteins appear to be found in both B and T cell extracts. To examine
whether the proteins that are unique to B cells play a role in the cell
type-specific expression of immunoglobulin, T cell transfectants
containing cloned B cell-specific genes will be produced and examined
for their ability to express and regulate B cell-specific genes.
These studies should provide insight into mechanisms by which proteins
regulate increased transcription in a cell type-specific manner, and may
lead to the identification of other important B cell proteins required
for intracellular signaling in response to IL-5 and antigen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ARID3a, a repressor in aged kidney progenitors?
-
批准号:10390496
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2022
-
负责人:Carol F Webb
-
依托单位:
Low density neutrophils and lupus
-
批准号:10743175
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2022
-
负责人:Carol F Webb
-
依托单位:
Identification of Proteins Interacting with ARID3a
-
批准号:9248234
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2016
-
负责人:Carol F Webb
-
依托单位:
Role of the transcription factor ARID3a in lupus
-
批准号:8074998
-
项目类别:
-
资助金额:$20.17万
-
财政年份:2010
-
负责人:Carol F Webb
-
依托单位:
Role of the transcription factor ARID3a in lupus
-
批准号:7976566
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2010
-
负责人:Carol F Webb
-
依托单位:
Bright Function in the Immune System
-
批准号:7210618
-
项目类别:
-
资助金额:$29.3万
-
财政年份:2005
-
负责人:Carol F Webb
-
依托单位:
Bright Function in the Immune System
-
批准号:7393813
-
项目类别:
-
资助金额:$28.74万
-
财政年份:2005
-
负责人:Carol F Webb
-
依托单位:
Bright Function in the Immune System
-
批准号:6866041
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2005
-
负责人:Carol F Webb
-
依托单位:
Bright Function in the Immune System
-
批准号:7024424
-
项目类别:
-
资助金额:$30.17万
-
财政年份:2005
-
负责人:Carol F Webb
-
依托单位:
Bright Function in the Immune System
-
批准号:7586743
-
项目类别:
-
资助金额:$29.58万
-
财政年份:2005
-
负责人:Carol F Webb
-
依托单位:
Pilot Projects
-
批准号:6847233
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2004
-
负责人:Carol F Webb
-
依托单位:
Expression and Function of Human BRIGHT
-
批准号:6340728
-
项目类别:
-
资助金额:$15.5万
-
财政年份:2000
-
负责人:Carol F Webb
-
依托单位:
Expression and Function of Human BRIGHT
-
批准号:6228588
-
项目类别:
-
资助金额:$15.5万
-
财政年份:1999
-
负责人:Carol F Webb
-
依托单位:
BRIGHT FUNCTION IN IMMUNODEFICIENCY DISEASE
-
批准号:2739703
-
项目类别:
-
资助金额:$20.56万
-
财政年份:1998
-
负责人:Carol F Webb
-
依托单位:
BRIGHT FUNCTION IN IMMUNODEFICIENCY DISEASE
-
批准号:6624542
-
项目类别:
-
资助金额:$23.58万
-
财政年份:1998
-
负责人:Carol F Webb
-
依托单位:
BRIGHT FUNCTION IN IMMUNODEFICIENCY DISEASE
-
批准号:6124229
-
项目类别:
-
资助金额:$21.57万
-
财政年份:1998
-
负责人:Carol F Webb
-
依托单位:
BRIGHT FUNCTION IN IMMUNODEFICIENCY DISEASE
-
批准号:6475525
-
项目类别:
-
资助金额:$22.89万
-
财政年份:1998
-
负责人:Carol F Webb
-
依托单位:
BRIGHT FUNCTION IN IMMUNODEFICIENCY DISEASE
-
批准号:6328806
-
项目类别:
-
资助金额:$22.22万
-
财政年份:1998
-
负责人:Carol F Webb
-
依托单位:
B CELL REGULATION BY INTERLEUKIN-5 + ANTIGEN
-
批准号:3468568
-
项目类别:
-
资助金额:$10.06万
-
财政年份:1992
-
负责人:Carol F Webb
-
依托单位:
B CELL REGULATION BY INTERLEUKIN 5 PLUS ANTIGEN
-
批准号:2183945
-
项目类别:
-
资助金额:$12.18万
-
财政年份:1992
-
负责人:Carol F Webb
-
依托单位:
海外基金